Back
Leap Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
13
LPTX
Leap Therapeutics
Last Price:
2.68
Seasonality Move:
2.21%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Sell
13
Leap Therapeutics (LPTX)
is a Sell
Is Leap Therapeutics a Buy, Sell or Hold?
- The current Leap Therapeutics [LPTX] share price is $2.70. The Score for LPTX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- LPTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LPTX Stock Price Chart
What is Leap Therapeutics's stock price today?
-
The Leap Therapeutics share price today is $2.70
The current trend is relatively stagnant and LPTX is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.43
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
LPTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 49.6 | Sell |
Chaikin Money Flow: | 17536 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.7 - 2.9) | Sell |
Bollinger Bands (100): | (2.05 - 2.77) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.8 | Buy |
Relative Strength Index (14 RSI): | 43.18 | Sell |
Chaikin Money Flow: | -435004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.76 - 58.26) | Sell |
Bollinger Bands (100): | (40.14 - 54.08) | Buy |
LPTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.72 | Sell |
20-day SMA: | 2.79 | Sell |
50-day SMA: | 2.56 | Buy |
200-day SMA: | 2.74 | Sell |
8-day EMA: | 2.7 | Sell |
20-day EMA: | 2.73 | Sell |
50-day EMA: | 2.62 | Buy |
200-day EMA: | 2.74 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.08 | Sell |
20-day SMA: | 56.96 | Sell |
50-day SMA: | 52.99 | Buy |
200-day SMA: | 46.88 | Buy |
8-day EMA: | 56.5 | Sell |
20-day EMA: | 56.46 | Sell |
50-day EMA: | 53.4 | Buy |
200-day EMA: | 47.32 | Buy |
Leap Therapeutics Earnings Growth & LPTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.13 per share, an increase this year of $1.53 per share, and an increase next year of $0.54 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Leap Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |